304: Success of Immune Monitoring with ImmuKnow (Cylex) To Assess Rejection/Infectious Risk in Heart Transplantation von Kobashigawa, J.A, Kiyosaki, K.K, Patel, J.K, Kittleson, M.M, Ardehali, A

Volltext

390: When Is Too Old, Too Old for Redo Heart Transplantation? von Patel, J, Kawano, M.A, Kiyosaki, K.K, Ankrom, A, Kittleson, M, Moriguchi, J, Ardehali, A, Kobashigawa, J

Volltext

81: Malignancy Risk in 2007 with Current Immunosuppression Regimens von Patel, J.K, Brown, A, Kittleson, M.M, Kawano, J.C, Kawano, M.A, Kiyosaki, K.K, Ardehali, A, Kobashigawa, J.A

Volltext

80: End-Stage Renal Disease after Heart Transplantation: The Benefits of Kidney Transplantation von Kittleson, M.M, Song, H.S, Patel, J.K, Kawano, M.A, Patel, D, Kiyosaki, K.K, Ardehali, A, Kobashigawa, J.A

Volltext

163: Everolimus May Have Lower Adverse Effect Profile Compared to Sirolimus in Heart Transplant Patients von Kittleson, M.M, Carr, S.A, Patel, J.K, Kawano, M.A, Kiyosaki, K.K, Ankrom, A.K, Ardehali, A, Kobashigawa, J.A

Volltext

303: Hemodynamic Compromise Rejection: Does the Heart Biopsy Influence Outcome? von Patel, J.K, Itagaki, B, Ankrom, A, Kawano, M, Kiyosaki, K.K, Yajnik, M, Ardehali, A, Kobashigawa, J

Volltext